Schroder Investment Management Group’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,917	Closed	-$254K	–	1230
2023 Q3	$254K	Buy	+7,917	New	+$254K	﹤0.01%	1154
2023 Q2	–	Sell	-7,066	Closed	-$298K	–	1259
2023 Q1	$298K	Buy	+7,066	New	+$298K	﹤0.01%	1182